267 related articles for article (PubMed ID: 10332210)
1. [Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis].
Okuda Y; Yamada T; Takasugi K; Takeda M; Nanba S; Onishi M; Miyamoto T; Inoue Y
Ryumachi; 1999 Feb; 39(1):3-10. PubMed ID: 10332210
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
[TBL] [Abstract][Full Text] [Related]
3. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
[TBL] [Abstract][Full Text] [Related]
4. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of serum amyloid A1 alleles by PCR-RFLP].
Yamada T; Itoh Y; Itoh K
Rinsho Byori; 1999 Jan; 47(1):53-5. PubMed ID: 10067365
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein.
Kumon Y; Loose LD; Birbara CA; Sipe JD
J Rheumatol; 1997 Jan; 24(1):14-9. PubMed ID: 9002005
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E phenotypes in rheumatoid arthritis with or without amyloidosis.
Maury CP; Liljeström M; Tiitinen S; Laiho K; Kaarela K; Ehnholm C
Amyloid; 2001 Dec; 8(4):270-3. PubMed ID: 11791620
[TBL] [Abstract][Full Text] [Related]
8. [Secondary amyloidosis complicated rheumatoid arthritis, prevalence study in Italian population].
Benucci M; Maniscalchi F; Manfredi M
Recenti Prog Med; 2007 Jan; 98(1):16-9. PubMed ID: 17345875
[TBL] [Abstract][Full Text] [Related]
9. [Current methods of systemic amyloidosis diagnosis and monitoring of its course].
Rameev VV; Kozlovskaia LV; Malinina EA; Serova AG; Kogarko IN; Kogarko BS; Liubimova NV
Ter Arkh; 2011; 83(8):48-54. PubMed ID: 21961333
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis.
Hasegawa H; Nishi S; Ito S; Saeki T; Kuroda T; Kimura H; Watababe T; Nakano M; Gejyo F; Arakawa M
Arthritis Rheum; 1996 Oct; 39(10):1728-32. PubMed ID: 8843864
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
[TBL] [Abstract][Full Text] [Related]
12. [An AA-amyloidosis course in patients with rheumatoid arthritis].
Sarkisova IA; Rameev VV; Varshavskiĭ VA; Golitsyn EP; Kozlovskaia LV
Ter Arkh; 2006; 78(5):31-6. PubMed ID: 16889046
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of occurrence of apolipoprotein E isoforms in patients with various types of hyperlipoproteinemias].
Vrablík M; Horínek A; Ceska R; Poledne R; Hubácek M
Cas Lek Cesk; 1999 Aug; 138(16):491-4. PubMed ID: 10566225
[TBL] [Abstract][Full Text] [Related]
17. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
[TBL] [Abstract][Full Text] [Related]
18. [Rapidly progressed secondary amyloidosis in a patient with Still's disease with gamma-allele in his SAA 1 gene].
Kaneko N; Mimori A; Baba S; Nara H; Shirota Y; Nagashima T; Hirata D; Yoshio T; Okazaki H; Kano S; Minota S
Ryumachi; 2000 Jun; 40(3):633-8. PubMed ID: 10920689
[TBL] [Abstract][Full Text] [Related]
19. [Laboratory findings and serum levels of amyloid A and soluble interleukin-2 receptors in patients with renal amyloidosis].
Rysavá R; Merta M; Tesar V; Zabka J; Spicka I; Stejskalová A; Vernerová Z
Cas Lek Cesk; 1998 Feb; 137(4):107-9. PubMed ID: 9531732
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative analysis of serum amyloid A protein isotypes].
Yamada T
Rinsho Byori; 1990 Feb; 38(2):183-7. PubMed ID: 1691798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
